Cidofovir Vistide 375 mg injection

50mg Injection , Piece

4.5 (154)

40,000

Vistide 375mg Injection is an antiviral medicine used for the treatment of certain viral infections, especially cytomegalovirus (CMV) retinitis in patients with weakened immune systems. It belongs to the nucleotide analogue group and works by blocking viral DNA replication, thereby preventing the virus from multiplying and spreading. Vistide 50mg Injection may also be used for some resistant viral infections when other antiviral treatments are ineffective. It is administered under medical supervision with careful monitoring of kidney function and overall health.

Description

Introduction to Cidofovir Vistide 375mg Injection: 

Vistide 375mg Injection contains the active ingredient Cidofovir and is developed by Gilead Sciences. It is an antiviral medicine used to treat cytomegalovirus (CMV) retinitis, a serious viral infection of the retina, in adults with acquired immunodeficiency syndrome (AIDS) who are intolerant of, or have a contraindication to, other medicines used to treat CMV infections.

Vistide 375mg Injection works by selectively inhibiting CMV DNA polymerase, the enzyme that CMV uses to replicate its genetic material. Cidofovir is a nucleotide analogue that, once activated inside infected cells, mimics a DNA building block and is incorporated into the growing viral DNA chain, halting viral replication.

This medicine is administered intravenously in a hospital setting by a qualified healthcare professional, always in combination with oral probenecid and intravenous hydration to reduce the risk of kidney toxicity.

Uses of Vistide 375mg Injection:

  • Cytomegalovirus (CMV) Retinitis: Vistide 50mg is primarily used to treat cytomegalovirus (CMV) retinitis, a serious eye infection that commonly affects people with weakened immune systems, such as those with HIV/AIDS or after organ transplantation.
  • Other Viral Infections: Vistide 50mg may also be considered for the treatment of other viral infections caused by DNA viruses, such as acyclovir-resistant herpes simplex virus (HSV) infections and certain types of papillomaviruses (warts).

Mechanism of Action of Vistide 375mg Injection:

Vistide 375mg Injection exerts its antiviral effect by interfering with the viral DNA synthesis process. It is a nucleotide analogue of cytosine, one of the building blocks of DNA. When a virus infects a cell, it needs to replicate its DNA to reproduce and spread. Vistide 50mg  is taken up by the infected cells, and once inside, it is phosphorylated into an active form called Vistide 50mg  diphosphate.

Vistide 375mg Injection diphosphate competes with the natural building blocks of viral DNA, leading to chain termination during viral DNA replication. By halting the replication process, the virus’s ability to spread and infect other cells is inhibited, helping to control the viral infection.

Benefits Of Vistide 375mg Injection:

1. Effective Against Resistant Strains: Vistide 50mg is valuable in cases where other antiviral drugs have failed, especially in treating CMV infections that are resistant to drugs like ganciclovir.

2. Potency: Vistide 50mg has demonstrated potent antiviral activity against various DNA viruses, making it a valuable treatment option in specific clinical scenarios.

Contact Us

Info Table
Packaging Size 75 mg/ml
Brand Vistide 375 mg
Form Injection
Pack Size 75 mg/ml
Manufacturer Gilead
Packaging Type Box
Composition Cidofovir
Prescription/Non prescription Non Prescription
Treatment Cytomegalovirus (CMV) Retinitis
Strength 375 mg
Generic Name Cidofovir
Packing Type Vial
Medicine Type Allopathic
Vendor Info
Benefits
Reviews

Description

Introduction to Cidofovir Vistide 375mg Injection: 

Vistide 375mg Injection contains the active ingredient Cidofovir and is developed by Gilead Sciences. It is an antiviral medicine used to treat cytomegalovirus (CMV) retinitis, a serious viral infection of the retina, in adults with acquired immunodeficiency syndrome (AIDS) who are intolerant of, or have a contraindication to, other medicines used to treat CMV infections.

Vistide 375mg Injection works by selectively inhibiting CMV DNA polymerase, the enzyme that CMV uses to replicate its genetic material. Cidofovir is a nucleotide analogue that, once activated inside infected cells, mimics a DNA building block and is incorporated into the growing viral DNA chain, halting viral replication.

This medicine is administered intravenously in a hospital setting by a qualified healthcare professional, always in combination with oral probenecid and intravenous hydration to reduce the risk of kidney toxicity.

Uses of Vistide 375mg Injection:

  • Cytomegalovirus (CMV) Retinitis: Vistide 50mg is primarily used to treat cytomegalovirus (CMV) retinitis, a serious eye infection that commonly affects people with weakened immune systems, such as those with HIV/AIDS or after organ transplantation.
  • Other Viral Infections: Vistide 50mg may also be considered for the treatment of other viral infections caused by DNA viruses, such as acyclovir-resistant herpes simplex virus (HSV) infections and certain types of papillomaviruses (warts).

Mechanism of Action of Vistide 375mg Injection:

Vistide 375mg Injection exerts its antiviral effect by interfering with the viral DNA synthesis process. It is a nucleotide analogue of cytosine, one of the building blocks of DNA. When a virus infects a cell, it needs to replicate its DNA to reproduce and spread. Vistide 50mg  is taken up by the infected cells, and once inside, it is phosphorylated into an active form called Vistide 50mg  diphosphate.

Vistide 375mg Injection diphosphate competes with the natural building blocks of viral DNA, leading to chain termination during viral DNA replication. By halting the replication process, the virus’s ability to spread and infect other cells is inhibited, helping to control the viral infection.

Benefits Of Vistide 375mg Injection:

1. Effective Against Resistant Strains: Vistide 50mg is valuable in cases where other antiviral drugs have failed, especially in treating CMV infections that are resistant to drugs like ganciclovir.

2. Potency: Vistide 50mg has demonstrated potent antiviral activity against various DNA viruses, making it a valuable treatment option in specific clinical scenarios.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Cidofovir Vistide 375 mg injection”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Cidofovir Vistide 375mg Injection used for?
Cidofovir Vistide 375 mg Injection is an antiviral medicine used to treat cytomegalovirus (CMV) retinitis in patients with weakened immune systems, such as those with HIV/AIDS.
It is administered under medical supervision, typically via IV infusion, with careful monitoring of kidney function before and during treatment.
The main risk is potential kidney toxicity, so regular kidney function tests and adequate hydration are important throughout treatment. For more clinical details, see MedlinePlus: Cidofovir Injection.
It works by blocking viral DNA replication, preventing the virus from multiplying and spreading further in the body.
Yes, it may be used for certain resistant viral infections, including CMV strains resistant to ganciclovir and some acyclovir-resistant HSV infections.
Cidofovir Vistide 375 mg Injection is manufactured by Gilead, containing Cidofovir, and supplied as a vial for prescription use.

Related products